Portfolio News VahatiCor Kathryn Deebel 11/18/25 VahatiCor Kathryn Deebel 11/18/25 VahatiCor Closes Oversubscribed Series B Financing to Accelerate A-FLUX® Development for Coronary Microvascular Dysfunction. Read More
VahatiCor Kathryn Deebel 11/18/25 VahatiCor Kathryn Deebel 11/18/25 VahatiCor Closes Oversubscribed Series B Financing to Accelerate A-FLUX® Development for Coronary Microvascular Dysfunction. Read More